Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver
- PMID: 20657216
- DOI: 10.1097/RCT.0b013e3181da3671
Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver
Abstract
Objectives: To evaluate the diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) for the characterization of hepatocellular carcinoma (HCC) and dysplastic nodule (DN) in cirrhotic liver, compared with contrast material-enhanced magnetic resonance imaging (CE-MRI).
Methods: A total of 54 patients with 40 HCC and 19 DN lesions were included in our study, and all lesions were histopathologically confirmed. All lesions were evaluated with CE-MRI, and breath-hold DWI was performed with b = 500 s/mm. The signal intensity (SI) of the lesions were classified as low, iso-, slightly high, and strongly high SI compared with that of the surrounding liver parenchyma on DWI for qualitative assessment. Apparent diffusion coefficients (ADCs) and lesion-to-liver ADC ratio of HCCs and DNs were measured and compared by using the Mann-Whitney U test. The lesions were characterized with the use of CE-MRI criteria and DWI, respectively. Receiver operating characteristic analysis was performed to assess the diagnostic value of DWI, CE-MRI, and these techniques combined in the differentiation of HCCs from DNs.
Results: In the qualitative analysis, among 40 HCCs, 39 (97.5%) had slightly high or strongly high SI on DWI, and 1 (2.5%) had low SI; only 4 (21.5%) of 19 DNs had slightly high SI, and 15 (78.95%) had iso-SI or low SI. The mean (SD) ADC and ADC ratio for HCCs (1.28 x 10 [0.25] mm/s and 0.88 [0.15], respectively) were significantly lower (P < 0.01 and P < 0.001, respectively) than those for DNs (1.53 x 10 [0.33] mm/s and 1.00 [0.08], respectively). The area, Az, under the receiver operating characteristic curve for the SI feature, the ADC ratio, and the ADCs based on the diagnosis of HCC versus DN were 0.88, 0.81, and 0.68, respectively. When the slightly high SI of lesion with a cutoff ADC ratio less than 0.92 was applied as a criterion, the Az, the sensitivity, the specificity, and the accuracy of DWI for the diagnosis of HCC versus DN were 0.81, 67.50%, 94.74%, and 76.27%, respectively. The corresponding Az, sensitivity, specificity, and accuracy of CE-MRI were 0.70, 82.50%, 57.89%, and 74.58%, respectively. Combined DWI plus CE-MRI had 0.91 Az, 97.50% sensitivity, and 93.22% accuracy, which increased significantly compared with those of CE-MRI alone.
Conclusions: Diffusion-weighted MRI can provide additional information to differentiate HCC from DN. Combined with CE-MRI, DWI allows improved characterization of HCC versus DN in cirrhotic liver.
Similar articles
-
Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.AJR Am J Roentgenol. 2011 Nov;197(5):W868-75. doi: 10.2214/AJR.10.6237. AJR Am J Roentgenol. 2011. PMID: 22021534
-
Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.J Magn Reson Imaging. 2009 Feb;29(2):341-9. doi: 10.1002/jmri.21650. J Magn Reson Imaging. 2009. PMID: 19161186
-
The value of gadobenate dimeglumine-enhanced delayed phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver.Invest Radiol. 2008 Mar;43(3):202-10. doi: 10.1097/RLI.0b013e31815d6929. Invest Radiol. 2008. PMID: 18301317
-
A pooled analysis of diffusion-weighted imaging in the diagnosis of hepatocellular carcinoma in chronic liver diseases.J Gastroenterol Hepatol. 2013 Feb;28(2):227-34. doi: 10.1111/jgh.12054. J Gastroenterol Hepatol. 2013. PMID: 23190006 Review.
-
Hepatocellular nodules in liver cirrhosis: MR evaluation.Abdom Imaging. 2011 Jun;36(3):282-9. doi: 10.1007/s00261-011-9692-2. Abdom Imaging. 2011. PMID: 21399975 Review.
Cited by
-
Magnetic resonance imaging of the cirrhotic liver: An update.World J Hepatol. 2015 Mar 27;7(3):468-87. doi: 10.4254/wjh.v7.i3.468. World J Hepatol. 2015. PMID: 25848471 Free PMC article. Review.
-
Hypovascular hypointense nodules on hepatobiliary phase without T2 hyperintensity on gadoxetic acid-enhanced MR images in patients with chronic liver disease: long-term outcomes and risk factors for hypervascular transformation.Eur Radiol. 2016 Oct;26(10):3728-36. doi: 10.1007/s00330-015-4146-9. Epub 2015 Dec 15. Eur Radiol. 2016. PMID: 26670318
-
Diagnosis of Hepatocellular Carcinoma with Gadoxetic Acid-Enhanced MRI: 2016 Consensus Recommendations of the Korean Society of Abdominal Radiology.Korean J Radiol. 2017 May-Jun;18(3):427-443. doi: 10.3348/kjr.2017.18.3.427. Epub 2017 Apr 3. Korean J Radiol. 2017. PMID: 28458595 Free PMC article. Review.
-
Differentiation of early hepatocellular carcinoma from benign hepatocellular nodules on gadoxetic acid-enhanced MRI.Br J Radiol. 2012 Oct;85(1018):e837-44. doi: 10.1259/bjr/13212920. Epub 2012 May 2. Br J Radiol. 2012. PMID: 22553295 Free PMC article.
-
[Rational imaging of hepatocellular carcinoma. The challenge of multimodal diagnostic criteria].Radiologe. 2014 Jul;54(7):664-72. doi: 10.1007/s00117-014-2652-4. Radiologe. 2014. PMID: 25047522 German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical